• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极低出生体重儿的液体限制与预防性吲哚美辛治疗

Fluid restriction and prophylactic indomethacin in extremely low birth weight infants.

作者信息

Anabrees Jasim A, Aifaleh Khalid M

机构信息

Neonatal Care, Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.

出版信息

J Clin Neonatol. 2012 Jan;1(1):1-5. doi: 10.4103/2249-4847.92228.

DOI:10.4103/2249-4847.92228
PMID:24027673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3761987/
Abstract

Although survival of extremely low birth weight (ELBW) infants dramatically improved over last decades, bronchopulmonary dysplasia (BPD) rate has not changed. The use of indomethacin prophylaxis in ELBW infants results in improved short-term outcomes with no effect on long-term outcomes. The addition of fluid restriction to the indomethacin prophylaxis policy could result in a reduction of BPD and improve long-term survival without neurosensory impairment at 18 months corrected age. To determine the effect of a policy of fluid restriction compared with a policy of no fluid restriction on morbidity and mortality in ELBW infants receiving indomethacin prophylaxis. The standard search strategy for the Cochrane Neonatal Review Group was used. This included search of OVID MEDLINE-National Library of Medicine, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 8, 2011). Additional search included conference proceedings, references in articles, and unpublished data. All randomized or quasi-randomized trials that compared fluid restriction and indomethacin prophylaxis vs. indomethacin prophylaxis alone in ELBW infants were included. Standard methods of the Cochrane Neonatal Review Group were planned to assess the methodological quality of the trials. Review Manager 5 software was planned to be used for statistical analysis. We found no randomized controlled trials to investigate the possible interaction between fluid restriction and indomethacin prophylaxis vs. indomethacin prophylaxis alone in ELBW infants. A well-designed randomized trial is needed to address this question.

摘要

尽管极低出生体重(ELBW)婴儿的存活率在过去几十年中有了显著提高,但支气管肺发育不良(BPD)的发生率并未改变。对ELBW婴儿使用吲哚美辛预防可改善短期结局,对长期结局无影响。在吲哚美辛预防方案中增加液体限制可降低BPD的发生率,并提高18个月矫正年龄时无神经感觉障碍的长期存活率。为了确定与无液体限制方案相比,液体限制方案对接受吲哚美辛预防的ELBW婴儿发病率和死亡率的影响。采用了Cochrane新生儿综述组的标准检索策略。这包括检索OVID MEDLINE-美国国立医学图书馆、EMBASE以及Cochrane对照试验中央注册库(CENTRAL,《Cochrane图书馆》,2011年第8期)。额外的检索包括会议论文集、文章中的参考文献以及未发表的数据。纳入了所有比较液体限制加吲哚美辛预防与单独使用吲哚美辛预防对ELBW婴儿影响的随机或半随机试验。计划采用Cochrane新生儿综述组的标准方法来评估试验的方法学质量。计划使用Review Manager 5软件进行统计分析。我们未发现有随机对照试验来研究在ELBW婴儿中液体限制与吲哚美辛预防联合使用与单独使用吲哚美辛预防之间可能存在的相互作用。需要进行一项设计良好的随机试验来解决这个问题。

相似文献

1
Fluid restriction and prophylactic indomethacin in extremely low birth weight infants.极低出生体重儿的液体限制与预防性吲哚美辛治疗
J Clin Neonatol. 2012 Jan;1(1):1-5. doi: 10.4103/2249-4847.92228.
2
Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants.液体限制联合预防性吲哚美辛与单独使用预防性吲哚美辛预防极低出生体重儿发病和死亡的比较
Cochrane Database Syst Rev. 2011 Jul 6(7):CD007604. doi: 10.1002/14651858.CD007604.pub2.
3
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003481. doi: 10.1002/14651858.CD003481.pub3.
4
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.预防性静脉注射吲哚美辛预防早产儿死亡和发病
Cochrane Database Syst Rev. 2010 Jul 7;2010(7):CD000174. doi: 10.1002/14651858.CD000174.pub2.
5
Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/ chronic lung disease.对于患有(或正在发展为)支气管肺发育不良/慢性肺病的早产儿,增加能量摄入。
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD005093. doi: 10.1002/14651858.CD005093.pub2.
6
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.预防性全身用抗真菌药物预防极低出生体重儿的死亡率和发病率。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD003850. doi: 10.1002/14651858.CD003850.pub3.
7
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.支气管肺发育不良、脑损伤和严重视网膜病变对极低出生体重儿18个月时预后的影响:早产儿吲哚美辛预防试验的结果
JAMA. 2003 Mar 5;289(9):1124-9. doi: 10.1001/jama.289.9.1124.
8
Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产儿和/或低出生体重儿的动脉导管未闭。
Cochrane Database Syst Rev. 2003(2):CD003481. doi: 10.1002/14651858.CD003481.
9
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.布洛芬用于治疗早产或低体重(或两者兼具)婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD003481. doi: 10.1002/14651858.CD003481.pub8.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

本文引用的文献

1
Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms.极低出生体重儿严重肺出血的预防及18个月预后:早产儿吲哚美辛预防试验的结果
Pediatrics. 2008 Feb;121(2):e233-8. doi: 10.1542/peds.2007-0028.
2
Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice.吲哚美辛对早产儿的预防作用:两项多中心随机对照试验对临床实践的影响。
J Pediatr. 2007 Jan;150(1):46-50.e2. doi: 10.1016/j.jpeds.2006.09.001.
3
Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).吲哚美辛预防、动脉导管未闭与支气管肺发育不良的风险:早产儿吲哚美辛预防试验(TIPP)的进一步分析
J Pediatr. 2006 Jun;148(6):730-734. doi: 10.1016/j.jpeds.2006.01.047.
4
Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.极低出生体重儿出生后十天内液体摄入量与体重减轻之间的关联以及支气管肺发育不良的风险
J Pediatr. 2005 Dec;147(6):786-90. doi: 10.1016/j.jpeds.2005.06.039.
5
Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age.贝利婴儿发育量表对极低出生体重儿童学龄期认知功能的预测效度不佳。
Pediatrics. 2005 Aug;116(2):333-41. doi: 10.1542/peds.2005-0173.
6
The International Classification of Retinopathy of Prematurity revisited.再探早产儿视网膜病变国际分类法。
Arch Ophthalmol. 2005 Jul;123(7):991-9. doi: 10.1001/archopht.123.7.991.
7
Validity of composite end points in clinical trials.临床试验中复合终点的有效性。
BMJ. 2005 Mar 12;330(7491):594-6. doi: 10.1136/bmj.330.7491.594.
8
Body water compartments in children: changes during growth and related changes in body composition.儿童的体液分布:生长过程中的变化及身体成分的相关变化。
Pediatrics. 1961 Aug;28:169-81.
9
Changes in body water compartments during growth.生长过程中身体水分 compartments 的变化。 (注:这里“compartments”可能是“compartments”拼写错误,推测可能是“compartments”,意为“部分、分区” ,结合语境可译为“身体水分分布区域” ,但按要求未作修改。)
Acta Paediatr Suppl (Upps). 1957 Jan;46(suppl 110):1-68.
10
Composite outcomes in randomized trials: greater precision but with greater uncertainty?随机试验中的复合结局:更高的精确性但伴随着更大的不确定性?
JAMA. 2003 May 21;289(19):2554-9. doi: 10.1001/jama.289.19.2554.